Fundz

Dexcel Pharma USA

New Jersey, United States · Biotechnology, Manufacturing, Pharmaceutical

Dexcel Pharma USA is the U.S. subsidiary of Dexcel Pharma, the largest private pharmaceutical company in Israel. It commercializes an extensive portfolio of branded and generic drugs. The company focuses on developing and manufacturing high-quality products. It also strives to maintain long-term partnerships across the value chain.

Key facts

Headquarters
New Jersey, United States
Employees
Unknown
Industries
Biotechnology, Manufacturing, Pharmaceutical
Status
Private
Website
dexcelpharmausa.com
LinkedIn
Company page

Recent activity at Dexcel Pharma USA

Leadership

  • Douglas, Chief Executive Officer
  • Daniel Connell, Chief Financial Officer

Verified email and direct lines for Dexcel Pharma USA’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Dexcel Pharma USA in the news

Companies similar to Dexcel Pharma USA

About Dexcel Pharma USA: questions and answers

What does Dexcel Pharma USA do?

Dexcel Pharma USA is the U.S. subsidiary of Dexcel Pharma, the largest private pharmaceutical company in Israel. It commercializes an extensive portfolio of branded and generic drugs. The company focuses on developing and manufacturing high-quality products. It also strives to maintain long-term partnerships across the value chain.

Where is Dexcel Pharma USA headquartered?

Dexcel Pharma USA is headquartered in New Jersey, United States.

Who leads Dexcel Pharma USA?

Douglas is a Chief Executive Officer at Dexcel Pharma USA.

What is the latest news on Dexcel Pharma USA?

On Aug 01, 2026, Dexcel Pharma USA Appoints Daniel Connell as Chief Financial Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Dexcel Pharma USA across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.